
Postdoctoral Fellow
Dr. Anil Bidkar is a Postdoctoral Fellow in the Department of Radiology and Biomedical Imaging. He achieved his doctoral degree from Indian Institute of Technology Guwahati, India. During his graduate studies, his research primarily centered on the development and application of nanomedicines, as well as the integration of novel and traditional therapies in cancer models. Dr. Bidkar is currently working on research projects within the area of radioligand therapy and imaging agent development. His focus is on advancing preclinical prostate cancer theranostics, with particular emphasis on PET imaging and treatment investigations.
Publications
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research
Modulation of Donor in Purely Organic Triplet Harvesting AIE-TADF Photosensitizer for Image-guided Photodynamic Therapy.
Small (Weinheim an der Bergstrasse, Germany)
PET Imaging Using 89Zr Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention (EPR) in Prostate Cancer.
Molecular cancer therapeutics
3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer.
Scientific reports
A technique to quantify very low activities in regions of interest with a collimatorless detector.
IEEE transactions on medical imaging
Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer.
Advanced healthcare materials
CD46-targeted theranostics for Positron Emission Tomography and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research
Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5.
Theranostics
Highly efficient color-tunable organic co-crystals unveiling polymorphism, isomerism, delayed fluorescence for optical waveguides and cell-imaging.
Nature communications
Coded aperture and Compton imaging for the development of 225 Ac-based radiopharmaceuticals.
Medical physics
Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair for 225Ac α-Radiotherapeutics.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research
CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment.
Journal of experimental & clinical cancer research : CR
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer.
Cancer research
Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers.
ACS applied materials & interfaces
Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen.
ACS applied materials & interfaces
Developing membrane-derived nanocarriers for ex vivo therapy of homologous breast cancer cells.
Nanomedicine (London, England)
A conformational tweak for enhanced cellular internalization, photobleaching resistance and prolonged imaging efficacy.
Chemical communications (Cambridge, England)
Peptide Hydrogels as Platforms for Sustained Release of Antimicrobial and Antitumor Drugs and Proteins.
ACS applied bio materials
Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections.
Biochimica et biophysica acta. Biomembranes
Red Blood Cell-Membrane-Coated Poly(Lactic-co-glycolic Acid) Nanoparticles for Enhanced Chemo- and Hypoxia-Activated Therapy.
ACS applied bio materials
Deciphering Hydrodynamic and Drug-Resistant Behaviors of Metastatic EMT Breast Cancer Cells Moving in a Constricted Microcapillary.
Journal of clinical medicine
Combination Therapy with MAPK-Pathway-Specific Inhibitor and Folic-Acid-Receptor-Targeted Selenium Nanoparticles Induces Synergistic Antiproliferative Response in BRAF Mutant Cancer Cells.
ACS biomaterials science & engineering
Insights into the Mechanism of Antimicrobial Activity of Seven-Residue Peptides.
Journal of medicinal chemistry
Efficient induction of apoptosis in cancer cells by paclitaxel-loaded selenium nanoparticles.
Nanomedicine (London, England)
Studying in vitro phagocytosis of apoptotic cancer cells by recombinant GMCSF-treated RAW 264.7 macrophages.
International journal of biological macromolecules
Protein folding and misfolding in the neurodegenerative disorders: a review.
Revue neurologique